Vericel Corp
XMUN:ATQP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
ABC Arbitrage SA
F:9BA
|
FR |
|
V
|
Viserve Enterprise PCL
SET:VS
|
TH |
|
Shanghai Electric Group Co Ltd
F:USR
|
CN |
|
I
|
Isracard Ltd
TASE:ISCD
|
IL |
|
C
|
CITIC Securities Co Ltd
XMUN:CI9
|
CN |
Intrinsic Value
Is ATQP undervalued or overvalued?
See the intrinsic value estimate for 
Vericel Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ATQP looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ATQP’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Vericel Does
Vericel Corp makes and sells specialty cell-therapy products for difficult orthopedic and burn injuries. Its main products are used by surgeons and hospitals to treat damaged knee cartilage and severe burns, where standard treatments may not work as well. The company focuses on very specific medical problems instead of broad drug categories.
- Headquarters
- United States of America US
- Employees
- 398
- IPO date
- Feb 4, 1997
Latest Earnings Call
- EPS
- $0.04
- Expected
- −$0.04
- Surprise
- +200.0%
- Stock, day of the call
- 0.0%
Revenue & Expenses Breakdown
Vericel Corp
Earnings Waterfall
Vericel Corp
The intrinsic value for Vericel Corp (ATQP) under the Base Case is hidden EUR.
Compared with the current market price of 36.2 EUR, the stock appears hidden.